Literature DB >> 34838262

An adversarial discriminative temporal convolutional network for EEG-based cross-domain emotion recognition.

Zhipeng He1, Yongshi Zhong1, Jiahui Pan2.   

Abstract

Domain adaptation (DA) tackles the problem where data from the source domain and target domain have different underlying distributions. In cross-domain (cross-subject or cross-dataset) emotion recognition based on EEG signals, traditional classification methods lack domain adaptation capabilities and have low performance. To address this problem, we proposed a novel domain adaptation strategy called adversarial discriminative-temporal convolutional networks (AD-TCNs) in this study, which can ensure the invariance of the representation of feature graphs in different domains and fill in the differences between different domains. For EEG data with specific temporal attributes, the temporal model TCN is used as the feature encoder. In the cross-subject experiment, our AD-TCN method achieved the highest accuracies of the valence and arousal dimensions in both the DREAMER and DEAP datasets. In the cross-dataset experiment, two of the eight task groups showed accuracies of 62.65% and 62.36%. Compared with the state-of-the-art performance in the same protocol, experimental results demonstrated that our method is an effective extension to realize EEG-based cross-domain emotion recognition.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Adversarial discriminative; Domain adaptation (DA); EEG; Emotion recognition; Temporal convolutional networks (TCN)

Mesh:

Year:  2021        PMID: 34838262     DOI: 10.1016/j.compbiomed.2021.105048

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  1 in total

1.  An improved multi-input deep convolutional neural network for automatic emotion recognition.

Authors:  Peiji Chen; Bochao Zou; Abdelkader Nasreddine Belkacem; Xiangwen Lyu; Xixi Zhao; Weibo Yi; Zhaoyang Huang; Jun Liang; Chao Chen
Journal:  Front Neurosci       Date:  2022-10-04       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.